|
Jul 29
|
Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze
|
|
Apr 10
|
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
|
|
Jun 3
|
Relief Therapeutics Announces Executive Changes
|
|
May 8
|
Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives
|
|
Dec 5
|
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
|